Prostate-specific antigen kinetics in localized and advanced prostate cancer.
about
Screening for prostate cancerScreening for prostate cancerA critical review of the analytical approaches for circulating tumor biomarker kinetics during treatmentCisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways.Age-specific prostate specific antigen cutoffs for guiding biopsy decision in Chinese population.Comparison of pathological and biochemical outcomes after radical prostatectomy in Korean patients with serum PSA ranges.Topoisomerase inhibitors modulate gene expression of B-cell translocation gene 2 and prostate specific antigen in prostate carcinoma cells.Differentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kinetics.The utility of prostate-specific antigen in the management of advanced prostate cancer.Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells.Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy.Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer.Evaluation of PSA-age volume score in predicting prostate cancer in Chinese populationArticle Subject.Standardization of assay methods reduces variability of total PSA measurements: an Irish study.
P2860
Q24201690-7E6047D3-D024-4AE4-923B-2B6843FF1689Q24245476-AE3522F4-FE1D-416D-9292-8F93F5196130Q26862558-C26D0DB4-C450-4787-9247-03B6278BE3ACQ33827212-3662316F-3D67-4715-9583-5F644E83307CQ34795029-CCF5CC8A-89FF-4050-9855-F31CCFC912CAQ35089346-11C74746-5E10-4F04-B738-901B733909FAQ35106686-70CF0467-FA46-4915-B337-F384777E3F80Q37037804-6FA17980-33B5-4DE1-84AA-1769942A2DA9Q38119260-58FF5305-5DE1-4951-94B8-2E5A63CDA0AEQ38179060-92C8A004-1A65-447E-837E-D5DFD8872248Q38923071-646688CA-5B67-4D73-B201-219FF3B707B4Q39470443-F0EB4074-BAC1-430C-AA82-0A302D33AFC9Q41650091-3935C0CB-A209-49B8-93AF-69600EA01B8AQ46874421-A74142CA-52DC-4AB8-9B15-A8700C15B9CFQ48500179-84830230-4452-4D3E-A425-C0A9D0FC978AQ50561785-720C52FC-10DB-4F88-B4FC-EC842F8FD4C4
P2860
Prostate-specific antigen kinetics in localized and advanced prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prostate-specific antigen kinetics in localized and advanced prostate cancer.
@en
Prostate-specific antigen kinetics in localized and advanced prostate cancer.
@nl
type
label
Prostate-specific antigen kinetics in localized and advanced prostate cancer.
@en
Prostate-specific antigen kinetics in localized and advanced prostate cancer.
@nl
prefLabel
Prostate-specific antigen kinetics in localized and advanced prostate cancer.
@en
Prostate-specific antigen kinetics in localized and advanced prostate cancer.
@nl
P2093
P1433
P1476
Prostate-specific antigen kinetics in localized and advanced prostate cancer.
@en
P2093
Eugeniu Banu
John M Fitzpatrick
Stephane Oudard
P304
P356
10.1111/J.1464-410X.2009.08345.X
P577
2009-02-06T00:00:00Z